Polyclonal Antibody to VKORC1

AP10371PU-N OriGene Technologies Inc. OriGene EU

Acris Antibodies GmbH 9620 Medical Center Drive, Ste 200 Schillerstr. 5 Rockville, MD 20850 32052 Herford UNITED STATES GERMANY Phone: +1-888-267-4436 Phone: +49-5221-34606-0 Fax: +1-301-340-8606 Fax: +49-5221-34606-11 [email protected] [email protected]

Polyclonal Antibody to VKORC1 (C-term) - Aff - Purified Alternate names: 3-epoxide reductase subunit 1, MSTP134, MSTP576, UNQ308/PRO351, VKOR, Vitamin K epoxide reductase complex subunit 1, Vitamin K1 2 Catalog No.: AP10371PU-N Quantity: 0.1 mg Concentration: 0.68 mg/ml. Background: Vitamin K is essential for blood clotting but must be enzymatically activated. vitamin K is primarily known as a cosubstrate in the posttranslational conversion of glutamate to γ- carboxyglutamate (Gla). There are at least 16 Gla-containing proteins in mammals, and eight of these are related to coagulation. This enzymatically activated form of vitamin K is a reduced form required for the carboxylation of glutamic acid residues in some blood- clotting proteins and the VKOR is the rate limiting enzyme in this pathway. The product of VKOR1 gene encodes the enzyme that is responsible for reducing vitamin K 2,3-epoxide to the enzymatically activated form. Vitamin K epoxide reductase (VKOR) is the target of warfarin, the most widely prescribed anticoagulant for thromboembolic disorders and its discovery led to better understanding of blood coagulation and development of anticoagulant drugs. Though VKOR was discovered in 1974, the enzyme has yet to be purified and characterized fully for its activity kinetics. Positional cloning approach has made possible to identify and map the VKOR gene to human chromosome 16p12-q21. The SiRNA experiment suggest that MGC11276 messenger RNA codes for 163 amino acid warfarin sensitive with at least one transmembrane domain VKOR1 protein (1). Coumarin derived drugs such as warfarin presents a long-term treatment and prevention of thromboembolic events by inhibiting VKOR multiprotein complex. Despite extensive efforts this complex has not yet fully identified. The VKOR complex recycle vitamin K 2,3-epoxide to vitamin K hydroquinone, a cofactor that is essential for the post translational gamma-carboxylation of several blood coagulation factors. The VKOR complex is implicated in at least 2 heritable human conditions, combined deficiency of vitamin-K-dependent clotting factors type 2 (VKCFD2; Online Mendelian Inheritance in Man (OMIM) 607473), and resistance to coumarin-type anticoagulant drugs (warfarin resistance, WR; OMIM 122700). The vitamin K epoxide reductase complex subunit 1 (VKORC1), which encodes a small transmembrane protein of the endoplasmic reticulum. The VKORC1 contains missense mutations in both human disorders and in a warfarin-resistant rat strain. Overexpression of wild-type VKORC1, but not VKORC1 carrying the VKCFD2 mutation, leads to a marked increase in VKOR activity, which is sensitive to warfarin inhibition (3). Atleast two pseudo genes for VKORC1 have been identified on chromosome 1 and X along with several alternatively spliced transcripts encoding different isoforms. Recently a recombinant VKORC1 was purified from virally infected SF9 cells and VKOR activity was preserved in this highly purified fraction (4). The VKOR1 is associated with microsomal membrane preparation. VKORC1 is a 163 amino acid protein, the recombinant VKORC1 was purified as a 21kDa protein with tag protein from Sf9 cells.

For research and in vitro use only. Not for diagnostic or therapeutic work. RS/20150324 Material Safety Datasheets are available at www.acris-antibodies.com or on request. Acris Antibodies is now part of the OriGene family. Learn more at www.origene.com 1 / 2 AP10371PU-N: Polyclonal Antibody to VKORC1 (C-term) - Aff - Purified Uniprot ID: Q6TEK4 NCBI: NP_976080 GeneID: 309004 Host / Isotype: Rabbit / IgG Immunogen: Synthetic peptides corresponding to C-terminal region (140-161) of Rat VKORC1. AA Sequence: ina glm lls fqk vpe hkv kkp Remarks: The peptide was covalently modified to achieve the desired antigenicity before coupling to carrier protein. Format: State: Liquid purified Ig fraction Purification: Affinity Chromatography Buffer System: Stabilization buffer with 0.02% Sodium Azide as preservative Applications: ELISA: 1/50,000 (peptide ELISA only) Western Blot Immunohistochemistry: 1/250 Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user. Specificity: This antibody labels VKORC1 protein in VKORC1 sample and in FOa1 cells as an approximate 20 kDa band. Species: Human, Mouse, and Rat. Other species not tested. Storage: Upon receipt, store undiluted (in aliquots) at -20°C. Avoid repeated freezing and thawing. Shelf life: one year from despatch. General Readings: 1. Li T, Chang CY, Jin DY, Lin PJ, Khvorova A, Stafford DW. Identification of the gene for vitamin K epoxide reductase. Nature. 2004 Feb 5;427(6974):541-4. PubMed PMID: 14765195. 2. Rost S, Fregin A, Ivaskevicius V, Conzelmann E, Hörtnagel K, Pelz HJ, Lappegard K, Seifried E, Scharrer I, Tuddenham EG, Müller CR, Strom TM, Oldenburg J. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature. 2004 Feb 5;427(6974):493-4. 3. Chu PH, Huang TY, Williams J, Stafford DW. Purified vitamin K epoxide reductase alone is sufficient for conversion of vitamin K epoxide to vitamin K and vitamin K to vitamin KH2. Proc Natl Acad Sci U S A. 2006 Dec 19;103(51):19308-13. Epub 2006 Dec 12. PubMed PMID: 17164330.